BACKGROUND: Nitric oxide is known to be essential for early anesthetic preconditioning (APC) and ischemic preconditioning (IPC) of myocardium. Heat shock protein 90 (Hsp90) regulates endothelial nitric oxide synthase (eNOS) activity. In this study, the authors tested the hypothesis that Hsp90-eNOS interactions modulate APC and IPC. METHODS: Myocardial infarct size was measured in rabbits after coronary occlusion and reperfusion in the absence or presence of preconditioning within 30 min of isoflurane (APC) or 5 min of coronary artery occlusion (IPC), and with or without pretreatment with geldanamycin or radicicol, two chemically distinct Hsp90 inhibitors, or N-nitro-L-arginine methyl ester, a nonspecific nitric oxide synthase NOS inhibitor. Isoflurane-dependent nitric oxide production was measured (ozone chemiluminescence) in human coronary artery endothelial cells or mouse cardiomyocytes, in the absence or presence of Hsp90 inhibitors or N-nitro-L-arginine methyl ester. Interactions between Hsp90 and eNOS, and eNOS activation, were assessed with immunoprecipitation, immunoblotting, and confocal microscopy. RESULTS: APC and IPC decreased infarct size (by 50% and 59%, respectively), and this action was abolished by Hsp90 inhibitors. N-nitro-L-arginine methyl ester blocked APC but not IPC. Isoflurane increased nitric oxide production in human coronary artery endothelial cells concomitantly with an increase in Hsp90-eNOS interaction (immunoprecipitation, immunoblotting, and immunohistochemistry). Pretreatment with Hsp90 inhibitors abolished isoflurane-dependent nitric oxide production and decreased Hsp90-eNOS interactions. Isoflurane did not increase nitric oxide production in mouse cardiomyocytes, and eNOS was below the level of detection. CONCLUSION: The results indicate that Hsp90 plays a critical role in mediating APC and IPC through protein-protein interactions, and suggest that endothelial cells are important contributors to nitric oxide-mediated signaling during APC.
BACKGROUND:Nitric oxide is known to be essential for early anesthetic preconditioning (APC) and ischemic preconditioning (IPC) of myocardium. Heat shock protein 90 (Hsp90) regulates endothelial nitric oxide synthase (eNOS) activity. In this study, the authors tested the hypothesis that Hsp90-eNOS interactions modulate APC and IPC. METHODS:Myocardial infarct size was measured in rabbits after coronary occlusion and reperfusion in the absence or presence of preconditioning within 30 min of isoflurane (APC) or 5 min of coronary artery occlusion (IPC), and with or without pretreatment with geldanamycin or radicicol, two chemically distinct Hsp90 inhibitors, or N-nitro-L-arginine methyl ester, a nonspecific nitric oxide synthase NOS inhibitor. Isoflurane-dependent nitric oxide production was measured (ozone chemiluminescence) in human coronary artery endothelial cells or mouse cardiomyocytes, in the absence or presence of Hsp90 inhibitors or N-nitro-L-arginine methyl ester. Interactions between Hsp90 and eNOS, and eNOS activation, were assessed with immunoprecipitation, immunoblotting, and confocal microscopy. RESULTS:APC and IPC decreased infarct size (by 50% and 59%, respectively), and this action was abolished by Hsp90 inhibitors. N-nitro-L-arginine methyl ester blocked APC but not IPC. Isoflurane increased nitric oxide production in human coronary artery endothelial cells concomitantly with an increase in Hsp90-eNOS interaction (immunoprecipitation, immunoblotting, and immunohistochemistry). Pretreatment with Hsp90 inhibitors abolished isoflurane-dependent nitric oxide production and decreased Hsp90-eNOS interactions. Isoflurane did not increase nitric oxide production in mouse cardiomyocytes, and eNOS was below the level of detection. CONCLUSION: The results indicate that Hsp90 plays a critical role in mediating APC and IPC through protein-protein interactions, and suggest that endothelial cells are important contributors to nitric oxide-mediated signaling during APC.
Authors: Jason Fontana; David Fulton; Yan Chen; Todd A Fairchild; Timothy J McCabe; Naoya Fujita; Takashi Tsuruo; William C Sessa Journal: Circ Res Date: 2002-05-03 Impact factor: 17.367
Authors: K A Pritchard; A W Ackerman; E R Gross; D W Stepp; Y Shi; J T Fontana; J E Baker; W C Sessa Journal: J Biol Chem Date: 2001-03-16 Impact factor: 5.157
Authors: Katsuya Tanaka; Dorothee Weihrauch; Franz Kehl; Lynda M Ludwig; John F LaDisa; Judy R Kersten; Paul S Pagel; David C Warltier Journal: Anesthesiology Date: 2002-12 Impact factor: 7.892
Authors: Yang Shi; John E Baker; Chenyang Zhang; James S Tweddell; Jidong Su; Kirkwood A Pritchard Journal: Circ Res Date: 2002-08-23 Impact factor: 17.367
Authors: Enis Novalija; Srinivasan G Varadarajan; Amadou K S Camara; Jianzhong An; Qun Chen; Matthias L Riess; Neil Hogg; David F Stowe Journal: Am J Physiol Heart Circ Physiol Date: 2002-07 Impact factor: 4.733
Authors: Zhi-Dong Ge; Danijel Pravdic; Martin Bienengraeber; Phillip F Pratt; John A Auchampach; Garrett J Gross; Judy R Kersten; David C Warltier Journal: Anesthesiology Date: 2010-01 Impact factor: 7.892
Authors: Junxia X Tang; Feras Mardini; Breanna M Caltagarone; Sean T Garrity; Rosie Q Li; Shannon L Bianchi; Olubusola Gomes; Frank M Laferla; Roderic G Eckenhoff; Maryellen F Eckenhoff Journal: Alzheimers Dement Date: 2011-07-13 Impact factor: 21.566
Authors: Zhi-Dong Ge; Irina A Ionova; Nikolina Vladic; Danijel Pravdic; Naoyuki Hirata; Jeannette Vásquez-Vivar; Phillip F Pratt; David C Warltier; Galen M Pieper; Judy R Kersten Journal: Cardiovasc Res Date: 2011-03-21 Impact factor: 10.787
Authors: Thorsten M Leucker; Martin Bienengraeber; Maria Muravyeva; Ines Baotic; Dorothee Weihrauch; Anna K Brzezinska; David C Warltier; Judy R Kersten; Phillip F Pratt Journal: J Mol Cell Cardiol Date: 2011-07-21 Impact factor: 5.000
Authors: Nikolina Vladic; Zhi-Dong Ge; Thorsten Leucker; Anna K Brzezinska; Jian-Hai Du; Yang Shi; David C Warltier; Phillip F Pratt; Judy R Kersten Journal: Am J Physiol Heart Circ Physiol Date: 2011-09-09 Impact factor: 4.733
Authors: Robert A Kloner; David A Brown; Marie Csete; Wangde Dai; James M Downey; Roberta A Gottlieb; Sharon L Hale; Jianru Shi Journal: Nat Rev Cardiol Date: 2017-07-27 Impact factor: 32.419